Cargando…
A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma †
Perineural invasion (PNI) is one of the major pathological characteristics of pancreatic ductal adeno-carcinoma (PDAC), which is mediated by invading cancer cells into nerve cells. Herein, we identify the overexpression of Interleukin-13 Receptor alpha2 (IL-13Rα2) in the PNI from 236 PDAC samples by...
Autores principales: | Fujisawa, Toshio, Shimamura, Takeshi, Goto, Kaku, Nakagawa, Ryo, Muroyama, Ryosuke, Ino, Yoshinori, Horiuchi, Hajime, Endo, Itaru, Maeda, Shin, Harihara, Yasushi, Nakajima, Atsushi, Matsuhashi, Nobuyuki, Kato, Naoya, Isayama, Hiroyuki, Puri, Ankit, Suzuki, Akiko, Bellayr, Ian, Leland, Pamela, Joshi, Bharat H., Puri, Raj K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281570/ https://www.ncbi.nlm.nih.gov/pubmed/32443847 http://dx.doi.org/10.3390/cancers12051294 |
Ejemplares similares
-
Prevalence Rate and Predictive Factors of Pancreatic Diseases in Cases with Pancreatic Duct Dilatation: A Cross-sectional Study of a Large, Healthy Japanese Population
por: Fujisawa, Toshio, et al.
Publicado: (2019) -
Analysis of interleukin-13 receptor alpha2 expression as a prognostic biomarker in surgically resected pancreatic cancer patients
por: Fujisawa, Toshio, et al.
Publicado: (2015) -
Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
por: Fujisawa, Toshio, et al.
Publicado: (2011) -
Interleukin 13 receptor alpha 2 directed immunotherapy targets hepatic fibrosis and tumorigenesis induced by choline deficient diet in an in vivo mouse model of nonalcoholic steatohepatitis
por: Fujisawa, Toshio, et al.
Publicado: (2014) -
Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer
por: Suzuki, Akiko, et al.
Publicado: (2019)